Article Versions Notes

Bovilla VR, Kuruburu MG, Bettada VG, Krishnamurthy J, Sukocheva OA, Thimmulappa RK, Shivananju NS, Balakrishna JP, Madhunapantula SV. Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo. Biomedicines. 2021; 9(9):1119. https://doi.org/10.3390/biomedicines9091119

Bovilla, Venugopal R., Mahadevaswamy G. Kuruburu, Vidya G. Bettada, Jayashree Krishnamurthy, Olga A. Sukocheva, Rajesh K. Thimmulappa, Nanjunda Swamy Shivananju, Janardhan P. Balakrishna, and SubbaRao V. Madhunapantula. 2021. "Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo" Biomedicines 9, no. 9: 1119. https://doi.org/10.3390/biomedicines9091119

Bovilla, V. R., Kuruburu, M. G., Bettada, V. G., Krishnamurthy, J., Sukocheva, O. A., Thimmulappa, R. K., Shivananju, N. S., Balakrishna, J. P., & Madhunapantula, S. V. (2021). Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo. Biomedicines, 9(9), 1119. https://doi.org/10.3390/biomedicines9091119